Gates Foundation Grants $13M to Lyndra Therapeutics for the Development of Once-Monthly Oral Contraceptive

Gates Foundation Grants $13M to Lyndra Therapeutics for the Development of Once-Monthly Oral Contraceptive

Shots:

  • The Gate Foundation has granted $13M to fund development program addressing the lack of global family planning options. The development of once-monthly oral contraceptive will provide women with a discreet, non-invasive option to support their family planning
  • Additionally, the Gates Foundation awarded a grant to Lyndra to develop long-acting malaria therapy and will provide funds for P-II clinical study, expansion of its P-I pipeline and manufacturing scale-up
  • Lyndra’s once-monthly oral combination therapy delivers sustained, the steady-state release of estrogen and progestin improving medication adherence and health outcomes while reducing the burdens on individuals and their caregivers

Click here to­ read full press release/ article | Ref: Lyndra Therapeutics | Image: The Pharma Letter